HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lin Yuan Selected Research

Alcoholic Cardiomyopathy

1/2012Chronic alcohol intake-induced oxidative stress and apoptosis: role of CYP2E1 and calpain-1 in alcoholic cardiomyopathy.
6/2011[Roles of PYK2 and caveolin-1 in alcoholic cardiomyopathy and the effect of drug intervention].
5/2011[Effect of valsartan and carnitine on cardiomyocyte Calpain-1 and Bcl-xl expressions of dogs with chronic alcohol intake-induced cardiomyopathy].
1/2011Carnitine regulates myocardial metabolism by Peroxisome Proliferator-Activated Receptor-alpha (PPARalpha) in alcoholic cardiomyopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lin Yuan Research Topics

Disease

87Neoplasms (Cancer)
11/2022 - 03/2002
27Breast Neoplasms (Breast Cancer)
01/2020 - 03/2002
25Urinary Bladder Neoplasms (Bladder Cancer)
05/2022 - 04/2010
25Infections
07/2021 - 01/2004
22Inflammation (Inflammations)
01/2022 - 03/2011
14Neoplasm Metastasis (Metastasis)
05/2022 - 12/2009
13Asthma (Bronchial Asthma)
01/2022 - 01/2018
11Carcinogenesis
01/2022 - 04/2010
8Hypoxia (Hypoxemia)
01/2022 - 05/2012
8Rheumatoid Arthritis
01/2021 - 12/2015
8Stomach Neoplasms (Stomach Cancer)
01/2021 - 01/2006
6Non-alcoholic Fatty Liver Disease
06/2022 - 01/2020
6Hepatocellular Carcinoma (Hepatoma)
01/2021 - 09/2008
6Carcinoma (Carcinomatosis)
03/2020 - 01/2006
6Prostatic Neoplasms (Prostate Cancer)
07/2017 - 09/2010
5Stroke (Strokes)
01/2021 - 06/2010
5Lung Neoplasms (Lung Cancer)
11/2020 - 09/2015
4Acute Kidney Injury (Acute Renal Failure)
12/2022 - 10/2018
4Pain (Aches)
11/2022 - 01/2012
4Parkinson Disease (Parkinson's Disease)
01/2022 - 01/2019
4Chemical and Drug Induced Liver Injury
01/2022 - 01/2020
4Wounds and Injuries (Trauma)
08/2021 - 06/2014
4Pneumonia (Pneumonitis)
02/2021 - 07/2015
4Whooping Cough (Pertussis)
01/2021 - 10/2014
4Fibrosis (Cirrhosis)
12/2020 - 06/2011
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018 - 01/2015
4Brain Injuries (Brain Injury)
01/2017 - 12/2012
4Ischemia
01/2016 - 08/2004
4Alcoholic Cardiomyopathy
01/2012 - 01/2011
3Communicable Diseases (Infectious Diseases)
09/2022 - 11/2020
3Periodontitis
05/2022 - 01/2016
3Liver Neoplasms (Liver Cancer)
04/2022 - 03/2008
3Pancreatitis
01/2022 - 09/2003
3Hyperglycemia
01/2022 - 12/2011
3Necrosis
01/2022 - 01/2021
3Hemorrhage
08/2021 - 04/2019
3Atherosclerosis
08/2021 - 01/2019
3HIV Infections (HIV Infection)
01/2021 - 04/2013
3Colonic Neoplasms (Colon Cancer)
01/2020 - 04/2014
3Ankylosing Spondylitis
01/2019 - 06/2013
3Acquired Immunodeficiency Syndrome (AIDS)
01/2018 - 01/2007

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
12/2022 - 05/2005
21Messenger RNA (mRNA)IBA
01/2022 - 04/2010
21MelatoninIBA
01/2021 - 03/2002
16Biomarkers (Surrogate Marker)IBA
06/2022 - 04/2010
13Biological ProductsIBA
05/2022 - 04/2005
13Pharmaceutical PreparationsIBA
09/2021 - 09/2005
13CytokinesIBA
01/2021 - 04/2013
11IntegrinsIBA
09/2022 - 02/2011
11Long Noncoding RNAIBA
07/2021 - 01/2014
10VaccinesIBA
01/2021 - 12/2006
9MicroRNAs (MicroRNA)IBA
11/2020 - 12/2012
8EnzymesIBA
01/2022 - 01/2006
8Therapeutic UsesIBA
01/2022 - 09/2003
8Estrogen Receptor alphaIBA
08/2015 - 03/2002
7Fluorescent Dyes (Fluorescent Probes)IBA
04/2022 - 02/2016
7MT1 Melatonin ReceptorIBA
06/2015 - 05/2005
6Molecular Probes (Molecular Probe)IBA
01/2022 - 02/2012
6Peroxynitrous Acid (Peroxynitrite)IBA
10/2021 - 01/2017
6InterleukinsIBA
07/2021 - 05/2013
6Phosphotransferases (Kinase)IBA
01/2020 - 08/2014
5RNA (Ribonucleic Acid)IBA
01/2022 - 07/2018
5Hydrogen Sulfide (Sulfide, Hydrogen)IBA
12/2021 - 06/2014
5GoldIBA
08/2021 - 03/2011
5SteroidsIBA
01/2021 - 11/2008
5Small Interfering RNA (siRNA)IBA
09/2020 - 01/2009
5Estrogens (Estrogen)FDA Link
01/2020 - 05/2005
5AntigensIBA
03/2019 - 04/2010
5DNA (Deoxyribonucleic Acid)IBA
02/2018 - 05/2005
5Estrogen ReceptorsIBA
08/2014 - 01/2010
4Anti-Bacterial Agents (Antibiotics)IBA
04/2022 - 12/2006
4Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2015
46-methyladenineIBA
01/2022 - 01/2020
4Adenosine Triphosphate (ATP)IBA
01/2021 - 11/2008
4Neuroprotective AgentsIBA
01/2021 - 09/2015
4IronIBA
01/2021 - 11/2014
4OsteopontinIBA
12/2020 - 02/2010
4Glucose (Dextrose)FDA LinkGeneric
11/2020 - 12/2011
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 10/2012
4Hormones (Hormone)IBA
02/2013 - 03/2002
4Melatonin Receptors (Melatonin Receptor)IBA
10/2011 - 06/2002
3Cisplatin (Platino)FDA LinkGeneric
12/2022 - 01/2014
3ProdrugsIBA
01/2022 - 11/2017
3alpha-SynucleinIBA
01/2022 - 01/2020
3Oxygen (Dioxygen)IBA
01/2022 - 12/2012
3AllergensIBA
11/2021 - 01/2018
3Peptides (Polypeptides)IBA
01/2021 - 12/2013
3Antiviral Agents (Antivirals)IBA
11/2020 - 04/2017
3PTEN Phosphohydrolase (PTEN Phosphatase)IBA
11/2020 - 09/2015
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 01/2009
3LipopolysaccharidesIBA
01/2020 - 11/2014
3Indicators and Reagents (Reagents)IBA
10/2019 - 12/2006
3MacrolidesIBA
03/2019 - 06/2008
3Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
07/2017 - 09/2003

Therapy/Procedure

27Therapeutics
05/2022 - 01/2007
8Drug Therapy (Chemotherapy)
11/2022 - 01/2009
4Photochemotherapy (Photodynamic Therapy)
01/2022 - 03/2014
4Aftercare (After-Treatment)
10/2020 - 07/2014
4Chinese Traditional Medicine (Traditional Chinese Medicine)
02/2020 - 06/2010
3Percutaneous Coronary Intervention
01/2020 - 06/2016